[Japon] Japan greenlights dexamethasone as second coronavirus treatment
Auteurs : Juntaro Arai, Nikkei staff writer
Production : Nikkei
Diffusion : site de Nikkei Asian Review
Date : 22 juillet 2020
Cheap anti-inflammatory wins fast-track approval after slashing mortality rates in UK hospital trial
TOKYO — The Japanese health ministry has authorized the anti-inflammatory drug dexamethasone to treat severe cases of COVID-19 after the inexpensive steroid lowered fatalities by roughly a third in a British trial, marking the second time a candidate has won fast-track approval.
Source : Juntaro Arai, « Japan greenlights dexamethasone as second coronavirus treatment », Nikkei Asian Review, 22/07/2020. URL : https://asia.nikkei.com/Spotlight/Coronavirus/Japan-greenlights-dexamethasone-as-second-coronavirus-treatment (consulté le 22/07/2020)
Photo « à la une » : A pharmacist holds an ampule of dexamethasone at a hospital in Belgium. © Reuters
OpenEdition vous propose de citer ce billet de la manière suivante :
IAOdocJ (22 juillet 2020). [Japon] Japan greenlights dexamethasone as second coronavirus treatment. Asie Orientale et Coronavirus. Consulté le 6 octobre 2024 à l’adresse https://doi.org/10.58079/n7h5
